| Yoga group (n = 29) | Control group (n = 28) | p-value |
---|---|---|---|
Age, years (mean ± SD) | 33.5 ± 11.4 | 33.4 ± 11.5 | 0.96 |
   Males, n (%) | 13 (45) | 20 (71) | 0.29 |
   Females, n (%) | 16 (55) | 8 (29) | 0.19 |
Weight, kg (mean ± SD) | 61.3 ± 11.5 | 58.9 ± 9.7 | 0.93 |
Height, cm (mean ± SD) | 162 ± 10.1 | 161.8 ± 7.4 | 0.40 |
Body Mass Index (BMI) (mean ± SD) | 23.4 ± 4.3 | 22.6 ± 4.0 | 0.44 |
Family history of asthma present, n (%) | 13 (44.8) | 11 (39.3) | 0.67 |
Duration of Asthma, years (mean ± SD) | 11.6 ± 9.5 | 10.5 ± 11.9 | 0.22 |
   Mild asthma, n (%) | 13 (44.8) | 11 (39.3) | 0.78 |
   Moderate asthma, n (%) | 16 (55) | 17 (60.7) | 0.82 |
FVC (% of predicted) | 78.7 ± 13.3 | 75.2 ± 15.0 | 0.35 |
FEV1 (% of predicted) | 70.2 ± 17.4 | 62.5 ± 19.2 | 0.11 |
FEV1/FVC (% of predicted) | 80.4 ± 11.5 | 73.7 ± 14.8 | 0.06 |
PEFR (% of predicted) | 68.6 ± 18.4 | 57.4 ± 19.7 | 0.03 |
FEF25-75 (% of predicted) | 38.4 ± 14.5 | 33.9 ± 18.3 | 0.31 |
Serum ECP level (ng/mL) | 1.32 ± 0.51 | 1.25 ± 0.43 | 0.89 |
EIB (%fall in FEV1 with EC) | 15.0 ± 14.0 | 9.1 ± 10.8 | 0.16 |
Urinary 11β-PGF2α before exercise (pg/mg of creatinine), median (IQR) | 455.4 (107.2–1098.1) | 223.7 (98.8–562.7) | 0.12 |
Δ Urinary 11β-PGF2α (pg/mg of creatinine) with exercise challenge, median (IQR) | 26.9 (7.4–218) | 38.4 (3.1–108) | 0.55 |
AQOL total score | 3.72 ± 1.17 | 3.64 ± 1.14 | 0.80 |
AQOL symptoms score | 3.77 ± 1.34 | 3.62 ± 1.42 | 0.70 |
AQOL activity limitation score | 3.66 ± 1.13 | 3.67 ± 1.17 | 0.95 |
AQOL emotional function score | 3.94 ± 1.47 | 3.59 ± 1.39 | 0.35 |
AQOL environmental stimuli score | 3.72 ± 1.17 | 4.04 ± 1.42 | 0.14 |